2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Elevance Health company profile · managed health care & Carelon services · history · financial snapshot · S&P 500 rank #135 · 信諾健康公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | ELV (NYSE) |
| Company | Elevance Health, Inc. |
| GICS sector / industry | Health Care (XLV) / Managed Health Care |
| S&P 500 rank (by weight) | #135 · 0.13% (Oct 31, 2026) |
| Sector rank (by market cap) | #21 in Health Care (Oct 31, 2026) |
| Headquarters | Indianapolis, Indiana |
| Founded | 1946, in Indianapolis (present form from the 2004 Anthem–WellPoint merger) |
| CEO | Gail K. Boudreaux (president and chief executive officer) |
| Employees | Approximately 97,100 (71,900 U.S., 25,200 international; Dec 31, 2025, FY2025 10-K) |
| Market cap | $90.76B (Oct 31, 2026) |
| SEC filings | EDGAR — CIK 0001156039 |
WHAT IT DOES
Elevance Health, formerly Anthem, Inc. until June 2022, is one of the largest health insurers in the United States by medical membership, serving approximately 45.2 million medical members through affiliated health plans, including Anthem Blue Cross and Blue Shield plans and Wellpoint. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association.
The company reports in Health Benefits and Carelon. Health Benefits — premiums of $159.46B plus service fees — produced FY2025 operating revenue of $167.09B and operating gain of $4.16B, down 33% year on year as benefit expense rose to $143.89B. CarelonRx (pharmacy services, product revenue $24.47B) produced $43.40B of operating revenue and $2.42B of operating gain; Carelon Services produced $28.32B and $0.96B. Total operating revenue was $197.58B and total operating gain $7.20B.
FY2025 total revenues were $199.13B, against $177.01B in FY2024, and net income was $5.66B, or $25.21 diluted EPS, against $25.68 in FY2024.
BUSINESS SEGMENTS — FY2025 OPERATING REVENUE
| Segment | Operating revenue | Share | YoY |
|---|---|---|---|
| Health Benefits | $167.09B | 84.6% | +11.2% |
| CarelonRx | $43.40B | 22.0% | +20.7% |
| Carelon Services | $28.32B | 14.3% | +57.7% |
| Corporate & Other | $0.46B | 0.2% | +49.8% |
| Eliminations | −$41.69B | −21.1% | — |
| Total operating revenue | $197.58B | 100% | +12.8% |
HISTORY
| Year | Milestone |
|---|---|
| 1946 | Founded in Indianapolis as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. |
| 2004 | Merger of Anthem and WellPoint Health Networks creates the present company form |
| 2022 | Renamed Elevance Health, Inc. (June 2022), from Anthem, Inc. |
| 2025 | FY2025: approximately 45.2 million medical members; total revenues $199.13B; net income $5.66B |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Total revenues | $199.13B (vs $177.01B in FY2024) |
| Total operating revenue | $197.58B (+12.8% YoY) |
| Total operating gain | $7.20B (vs $7.86B in FY2024, −8.4%) |
| Health Benefits operating gain | $4.16B (vs $6.24B in FY2024) |
| Net income | $5.66B |
| Diluted EPS | $25.21 (vs $25.68 in FY2024) |
| Medical members | Approximately 45.2 million |
| Employees | Approximately 97,100 (Dec 31, 2025) |
| Fiscal year | Ends Dec 31 (FY2025 ended Dec 31, 2025) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Elevance Health is the S&P 500’s managed-care read on medical costs: at a 0.13% index weight and #21 in Health Care by market cap, its benefit-expense trend and membership moves preview what the whole managed-care group will report.
Its Carelon arm also makes it a read on pharmacy and health-services outsourcing — the part of health care that grows even when insurance margins compress.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Oct 31, 2026 crawl) · StockAnalysis (market cap — Oct 31, 2026 crawl) |
| Financials | Elevance Health FY2025 Form 10-K (SEC EDGAR, filed Feb 6, 2026; fiscal year ended Dec 31, 2025) |
| Sector classification | GICS via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 代碼 | ELV(NYSE) |
| 公司 | Elevance Health, Inc. |
| GICS 板塊/行業 | 醫療保健(XLV)/管理式醫療保健 |
| 標普500排名(按權重) | #135 · 0.13%(2026 年 10 月 31 日) |
| 板塊內排名(按市值) | 醫療保健第 #21(2026 年 10 月 31 日) |
| 總部 | 美國印第安納州印第安納波利斯 |
| 成立 | 1946 年,於印第安納波利斯(現有形態源自 2004 年 Anthem 與 WellPoint 合併) |
| 行政總裁 | Gail K. Boudreaux(總裁兼行政總裁) |
| 員工 | 約 97,100(美國 71,900、國際 25,200;2025 年 12 月 31 日,FY2025 10-K) |
| 市值 | $90.76B(2026 年 10 月 31 日) |
| SEC 申報 | EDGAR — CIK 0001156039 |
業務概覽
信諾健康(2022 年 6 月前稱 Anthem, Inc.)是美國按醫療會員計最大的健康保險公司之一,透過附屬健康計劃(包括 Anthem Blue Cross and Blue Shield 計劃與 Wellpoint)服務約 4,520 萬名醫療會員,是 Blue Cross Blue Shield Association 內最大的營利性管理式醫療保健公司。
公司分健康福利與 Carelon 報告。健康福利——保費 $159.46B 加服務費——FY2025 營業收入 $167.09B,營業利潤 $4.16B,同比下跌 33%,因福利支出升至 $143.89B。CarelonRx(藥房服務,產品收入 $24.47B)營業收入 $43.40B,營業利潤 $2.42B;Carelon Services 營業收入 $28.32B,營業利潤 $0.96B。營業收入合計 $197.58B,營業利潤合計 $7.20B。
FY2025 總收入 $199.13B,FY2024 為 $177.01B;淨利潤 $5.66B,攤薄每股盈利 $25.21,FY2024 為 $25.68。
業務板塊 — FY2025 營業收入
| 板塊 | 營業收入 | 佔比 | 同比 |
|---|---|---|---|
| 健康福利 | $167.09B | 84.6% | +11.2% |
| CarelonRx | $43.40B | 22.0% | +20.7% |
| Carelon Services | $28.32B | 14.3% | +57.7% |
| 企業及其他 | $0.46B | 0.2% | +49.8% |
| 抵銷 | −$41.69B | −21.1% | — |
| 營業收入合計 | $197.58B | 100% | +12.8% |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1946 | 於印第安納波利斯創立,初名 Mutual Hospital Insurance Inc. 與 Mutual Medical Insurance Inc. |
| 2004 | Anthem 與 WellPoint Health Networks 合併,形成現有公司形態 |
| 2022 | 更名為 Elevance Health, Inc.(2022 年 6 月),前稱 Anthem, Inc. |
| 2025 | FY2025:醫療會員約 4,520 萬;總收入 $199.13B;淨利潤 $5.66B |
競爭地位
財務快照 — FY2025
| 總收入 | $199.13B(FY2024 為 $177.01B) |
| 營業收入合計 | $197.58B(同比 +12.8%) |
| 營業利潤合計 | $7.20B(FY2024 為 $7.86B,−8.4%) |
| 健康福利營業利潤 | $4.16B(FY2024 為 $6.24B) |
| 淨利潤 | $5.66B |
| 攤薄每股盈利 | $25.21(FY2024 為 $25.68) |
| 醫療會員 | 約 4,520 萬 |
| 員工 | 約 97,100(2025 年 12 月 31 日) |
| 財政年度 | 截至 12 月 31 日(FY2025 截至 2025 年 12 月 31 日) |
主要風險
對標普500的重要性
信諾健康是標普500的管理式醫療對醫療成本的讀數:指數權重 0.13%、醫療保健市值第 #21,其福利支出趨勢與會員變動預示整個管理式醫療板塊的業績。
其 Carelon 業務亦是藥房與健康服務外包的讀數——即使保險利潤受壓,該部分仍在增長。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 31 日抓取)· StockAnalysis(市值——2026 年 10 月 31 日抓取) |
| 財務 | 信諾健康 FY2025 Form 10-K(SEC EDGAR,2026 年 2 月 6 日申報;財政年度截至 2025 年 12 月 31 日) |
| 板塊分類 | GICS,據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-10-31 04:34 · updated 2026-11-14 23:23 · rev 6